Catalyst Wire Dossier Catalyst Wire Dossier

M5717-Pyronaridine

M5717 + Pyronaridine · Merck KGaA
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for M5717-Pyronaridine, covering 2025-08-27 to 2025-08-27. Get the full timeline:

Most recent: Clinical Trial Update: Phase IIa Proof of Concept Study of M5717-Pyronaridine in Adults and Adolescents With Acute Uncomplicated Plasmodium Falciparum Malaria (CAPTURE 1) [Phase 2]

See pricing